U.S. Retractable Needle Safety Syringes Market, by Product Type (Manual and Automated), by End User (Hospitals, Physician Offices, Nursing Home, Dental Laboratories, Diagnostic Centers, Ambulatory Surgical Centers, Homecare Settings, and Others (Clinics,

U.S. Retractable Needle Safety Syringes Market, by Product Type (Manual and Automated), by End User (Hospitals, Physician Offices, Nursing Home, Dental Laboratories, Diagnostic Centers, Ambulatory Surgical Centers, Homecare Settings, and Others (Clinics, Research Laboratories, Etc.)), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Drug Store, and E-Commerce) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

A needle is a solid and slender instrument, which is pointed at the end and is designed for puncturing of tissues. Safety needles have a safety mechanism built into the needles to protect healthcare workers and others from accidental needlestick injuries. They are used for different purposes such as drug delivery, vaccination, and blood specimen collection for examination and research purposes. Safety needles reduce the incidence of infection, cost as well as offer better convenience and practicality in use. Factors such as accuracy, operation time, and prompt use design were favorable with the majority of health care personnel preferring safety needle technology as compared to conventional devices. Various types of safety needles are available in the market that work on different mechanisms.
Market Dynamics
Rising prevalence of gynecologic cancer and spine disorders, government initiatives for blood collection and favorable reimbursement for pen needles are some of the major factors responsible for the growth of the U.S. retractable needle safety syringes market. For instance, according to the 2018 report published by the Centers for Disease Control and Prevention, in 2018, 883.7 million individuals including adults and children visited physician offices for the treatment of various conditions such as diabetes, cold and flu, and viral infection in the U.S. Moreover, increasing number of geriatric population patients is expected to drive demand for homecare settings, which boost growth of the U.S. safety needles market over the forecast period. For instance, according to the report published in 2021 by the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.
Key features of the study:
This report provides in-depth analysis of the U.S. retractable needle safety syringes market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the U.S. retractable needle safety syringes market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Medtronic Plc., Becton, Dickinson and Company, Boston Scientific Corporation, Smith Medical, Abbott Laboratories, Argon Medical Devices Inc., Novo Nordisk A/S, Terumo Corporation, Eli Lilly and Company, Nipro Corporation, B.Braun Melsungen AG, Revolutions Medical Corporation, Retractable Technologies, Inc, SOL-MILLENNUM, UltiMed, Inc., Axel Bio Corporation, Inc., Cardinal Health, Inc., Vygon S.A., and Gerresheimer AG.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The U.S. retractable needle safety syringes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S. retractable needle safety syringes market
Detailed Segmentation:
U.S. retractable needle safety syringes market, By Product Type :
Fine Aspirating Needle
Biopsy Needle
Hypodermic Needle
Pen Needle
Suture Needle
IV Catheter Needle
Huber Needle
Blood Collection Needle
Spinal Anesthesia and Epidural Needle
Prefilled Syringe Needle
A.V. Fistula Needle
Cannula Needle
Retractable Syringes
U.S. retractable needle safety syringes market, By Application:
Sample Collection
Drug Delivery
U.S. retractable needle safety syringes market, By End User:
Hospitals
Physician Offices
Nursing Home
Dental Laboratories
Diagnostic Centers
Ambulatory Surgical Centers
Homecare Settings
Others
U.S. retractable needle safety syringes market, By Distribution Channel
Hospital Pharmacies
Private Clinics
Retail Pharmacies and Drug Store
E-commerce
Company Profiles
Medtronic Plc*
Company Highlights
Product Portfolio
Key Highlights
Financial Overview
Strategy
Becton, Dickinson and Company
Boston Scientific Corporation
Smith Medical Company
Abbott Laboratories.
Argon Medical Devices, Inc.
Novo Nordisk A/S
Terumo Corporation
Eli Lilly and Company
Nipro Corporation
B.Braun Melsungen AG
Revolutions Medical Corporation
Retractable Technologies, Inc
SOL-MILLENNUM
UltiMed, Inc.
Axel Bio Corporation, Inc.
Cardinal Health, Inc.
Vygon S.A.
Gerresheimer AG
“*” marked represents similar segmentation in other categories in the respective section.